James Paul Scopa, Director at Trivascular Technologies, holds 103.33K shares in Adverum Biotechnologies (Ticker: ADVM), holds 183.08K shares in Aligos Therapeutics (Ticker: ALGS), holds 0.00 shares in Dice Therapeutics (Ticker: DICE). Most recently, James Paul Scopa Bought ― shares of Adverum Biotechnologies on Feb 09, 2024 for an estimated value of 135.00K.
What is the percentage of profitable transactions made by James Paul Scopa?
The percentage of profitable transactions made by James Paul Scopa is 40%.
What is the average return per transaction made by James Paul Scopa?
The average return per transaction made by James Paul Scopa is 30.80%.
What stocks does James Paul Scopa hold?
James Paul Scopa holds: TRIV, ADVM, ALGS, DICE, HSTO stocks.
What was James Paul Scopa’s latest transaction?
James Paul Scopa latest transaction was an Informative Buy of $135.00K.
What was James Paul Scopa's most profitable transaction?
James Paul Scopa’s most profitable transaction was an Informative Buy of ADVM stock on May 6, 2019. The return on the trade was 204.70%.
What is James Paul Scopa's role in Trivascular Technologies?
James Paul Scopa's role in Trivascular Technologies is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.